文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Atrophied brain lesion volume, a magnetic resonance imaging biomarker for monitoring neurodegenerative changes in multiple sclerosis.

作者信息

Zivadinov Robert, Bergsland Niels, Dwyer Michael G

机构信息

Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

Center for Biomedical Imaging, University at Buffalo, State University of New York, Buffalo, NY, USA.

出版信息

Quant Imaging Med Surg. 2018 Nov;8(10):979-983. doi: 10.21037/qims.2018.11.01.

DOI:10.21037/qims.2018.11.01
PMID:30598875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6288055/
Abstract
摘要

相似文献

[1]
Atrophied brain lesion volume, a magnetic resonance imaging biomarker for monitoring neurodegenerative changes in multiple sclerosis.

Quant Imaging Med Surg. 2018-11

[2]
Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis.

J Neuroimaging. 2018-6-1

[3]
A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.

AJNR Am J Neuroradiol. 2019-2-28

[4]
Atrophied T2 Lesion Volume in Multiple Sclerosis: Reducing the Focus on Lesion Counting.

Radiology. 2019-11

[5]
Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.

Brain. 2009-12

[6]
Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.

Neuroimaging Clin N Am. 2017-5

[7]
[Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].

Lijec Vjesn. 2006

[8]
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.

Brain. 1996-6

[9]
MR in the diagnosis and monitoring of multiple sclerosis: an overview.

Eur J Radiol. 2008-9

[10]
Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

Arch Neurol. 2001-1

引用本文的文献

[1]
Comparative analysis of neuroinflammatory pathways in Alzheimer's disease, Parkinson's disease, and multiple sclerosis: insights into similarities and distinctions.

Front Neurosci. 2025-4-29

[2]
Multicompartment imaging of the brain using a comprehensive MR imaging protocol.

Neuroimage. 2024-9

[3]
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis.

J Neurol. 2024-9

[4]
Consensus on early detection of disease progression in patients with multiple sclerosis.

Front Neurol. 2022-7-28

[5]
Current and Future Biomarkers in Multiple Sclerosis.

Int J Mol Sci. 2022-5-24

[6]
Potential Biomarkers Associated with Multiple Sclerosis Pathology.

Int J Mol Sci. 2021-9-25

[7]
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.

Brain. 2020-12-5

[8]
Detection of Monocyte/Macrophage and Microglia Activation in the TMEV Model of Chronic Demyelination Using USPIO-Enhanced Ultrahigh-Field Imaging.

J Neuroimaging. 2020-11

[9]
The association of myelination in the internal capsule with iron deposition in the basal ganglia in macaques: a magnetic resonance imaging study.

Quant Imaging Med Surg. 2020-7

[10]
Systematic review of prediction models in relapsing remitting multiple sclerosis.

PLoS One. 2020-5-26

本文引用的文献

[1]
Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis.

Radiology. 2018-7-17

[2]
Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis.

J Neuroimaging. 2018-6-1

[3]
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study.

Curr Med Res Opin. 2018-4-12

[4]
Use of brain diffusion tensor imaging for the prediction of long-term neurological outcomes in patients after cardiac arrest: a multicentre, international, prospective, observational, cohort study.

Lancet Neurol. 2018-2-27

[5]
Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease.

Ann Neurol. 2018-2-9

[6]
Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.

AJNR Am J Neuroradiol. 2017-11-23

[7]
Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.

Hum Brain Mapp. 2017-8

[8]
An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.

J Neuroimaging. 2017-5

[9]
Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review.

JAMA Neurol. 2017-1-1

[10]
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.

J Neurol Neurosurg Psychiatry. 2016-6-13

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索